SAGE Therapeutics Company
Brain focused: neurological and neuropsychiatric disorders, various neurodegenerative disorders, and depression.
.png)
.png)
Technology:
AgeTech Companies
Industry:
NeuroTech
Headquarters:
United Kingdom
Founded Date:
1/1/2010
Employees Number:
501-1000
Funding Status:
IPO
Investors Number:
6
Total Funding:
1088000000
Estimated Revenue:
$50M to $100M
Last Funding Date:
27 11 20
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership